世界の治療用ペプチド市場2021-2026:経口、注射、その他

LP Informationが発行した調査報告書(LPI21MY9670)
◆英語タイトル:Global Therapeutic Peptide Market Growth 2021-2026
◆商品コード:LPI21MY9670
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:100
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「治療用ペプチドの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経口、注射、その他など、用途別には、がん、代謝障害、中枢神経系、その他などにセグメント区分してまとめました。治療用ペプチドのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・治療用ペプチドの世界市場概要(サマリー)
・治療用ペプチドの企業別販売量・売上
・治療用ペプチドの企業別市場シェア
・治療用ペプチドの世界市場規模 2016年-2021年:種類別(経口、注射、その他)
・治療用ペプチドの世界市場規模 2016年-2021年:用途別(がん、代謝障害、中枢神経系、その他)
・治療用ペプチドの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・治療用ペプチドのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・治療用ペプチドのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・治療用ペプチドの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・治療用ペプチド市場の成長要因・課題・動向
・治療用ペプチドの世界市場予測 2021年-2026年
・治療用ペプチドの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・治療用ペプチドのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・治療用ペプチドのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・治療用ペプチドの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・治療用ペプチドの世界市場予測:種類別(経口、注射、その他)
・治療用ペプチドの世界市場予測:用途別(がん、代謝障害、中枢神経系、その他)
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Therapeutic Peptide will have significant change from previous year. By the most conservative estimates of global Therapeutic Peptide market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Therapeutic Peptide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Peptide market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Oral
Injection
Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Cancer
Metabolic Disorders
Central Nervous System
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
AbbVie
AstraZeneca
Ipsen
Eli Lilly
Merck
Novo Nordisk
Novartis
Johnson and Johnson
Sanofi
Teva
Takeda

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Peptide Consumption 2016-2026
2.1.2 Therapeutic Peptide Consumption CAGR by Region
2.2 Therapeutic Peptide Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Other
2.3 Therapeutic Peptide Sales by Type
2.3.1 Global Therapeutic Peptide Sales Market Share by Type (2016-2021)
2.3.2 Global Therapeutic Peptide Revenue and Market Share by Type (2016-2021)
2.3.3 Global Therapeutic Peptide Sale Price by Type (2016-2021)
2.4 Therapeutic Peptide Segment by Application
2.4.1 Cancer
2.4.2 Metabolic Disorders
2.4.3 Central Nervous System
2.4.4 Other
2.5 Therapeutic Peptide Sales by Application
2.5.1 Global Therapeutic Peptide Sale Market Share by Application (2016-2021)
2.5.2 Global Therapeutic Peptide Revenue and Market Share by Application (2016-2021)
2.5.3 Global Therapeutic Peptide Sale Price by Application (2016-2021)

3 Global Therapeutic Peptide by Company
3.1 Global Therapeutic Peptide Sales Market Share by Company
3.1.1 Global Therapeutic Peptide Sales by Company (2019-2021)
3.1.2 Global Therapeutic Peptide Sales Market Share by Company (2019-2021)
3.2 Global Therapeutic Peptide Revenue Market Share by Company
3.2.1 Global Therapeutic Peptide Revenue by Company (2019-2021)
3.2.2 Global Therapeutic Peptide Revenue Market Share by Company (2019-2021)
3.3 Global Therapeutic Peptide Sale Price by Company
3.4 Global Manufacturers Therapeutic Peptide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Peptide Product Location Distribution
3.4.2 Players Therapeutic Peptide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Therapeutic Peptide by Region
4.1 Global Therapeutic Peptide by Region
4.1.1 Global Therapeutic Peptide Sales by Region
4.1.2 Global Therapeutic Peptide Revenue by Region
4.2 Americas Therapeutic Peptide Sales Growth
4.3 APAC Therapeutic Peptide Sales Growth
4.4 Europe Therapeutic Peptide Sales Growth
4.5 Middle East & Africa Therapeutic Peptide Sales Growth

5 Americas
5.1 Americas Therapeutic Peptide Sales by Country
5.1.1 Americas Therapeutic Peptide Sales by Country (2016-2021)
5.1.2 Americas Therapeutic Peptide Revenue by Country (2016-2021)
5.2 Americas Therapeutic Peptide Sales by Type
5.3 Americas Therapeutic Peptide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Therapeutic Peptide Sales by Region
6.1.1 APAC Therapeutic Peptide Sales by Region (2016-2021)
6.1.2 APAC Therapeutic Peptide Revenue by Region (2016-2021)
6.2 APAC Therapeutic Peptide Sales by Type
6.3 APAC Therapeutic Peptide Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Therapeutic Peptide by Country
7.1.1 Europe Therapeutic Peptide Sales by Country (2016-2021)
7.1.2 Europe Therapeutic Peptide Revenue by Country (2016-2021)
7.2 Europe Therapeutic Peptide Sales by Type
7.3 Europe Therapeutic Peptide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Peptide by Country
8.1.1 Middle East & Africa Therapeutic Peptide Sales by Country (2016-2021)
8.1.2 Middle East & Africa Therapeutic Peptide Revenue by Country (2016-2021)
8.2 Middle East & Africa Therapeutic Peptide Sales by Type
8.3 Middle East & Africa Therapeutic Peptide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Therapeutic Peptide Distributors
10.3 Therapeutic Peptide Customer

11 Global Therapeutic Peptide Market Forecast
11.1 Global Therapeutic Peptide Forecast by Region
11.1.1 Global Therapeutic Peptide Forecast by Regions (2021-2026)
11.2.2 Global Therapeutic Peptide Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Therapeutic Peptide Forecast by Type
11.7 Global Therapeutic Peptide Forecast by Application

12 Key Players Analysis
12.1 AbbVie
12.1.1 AbbVie Company Information
12.1.2 AbbVie Therapeutic Peptide Product Offered
12.1.3 AbbVie Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 AbbVie Main Business Overview
12.1.5 AbbVie Latest Developments
12.2 AstraZeneca
12.2.1 AstraZeneca Company Information
12.2.2 AstraZeneca Therapeutic Peptide Product Offered
12.2.3 AstraZeneca Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 AstraZeneca Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Ipsen
12.3.1 Ipsen Company Information
12.3.2 Ipsen Therapeutic Peptide Product Offered
12.3.3 Ipsen Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Ipsen Main Business Overview
12.3.5 Ipsen Latest Developments
12.4 Eli Lilly
12.4.1 Eli Lilly Company Information
12.4.2 Eli Lilly Therapeutic Peptide Product Offered
12.4.3 Eli Lilly Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Eli Lilly Main Business Overview
12.4.5 Eli Lilly Latest Developments
12.5 Merck
12.5.1 Merck Company Information
12.5.2 Merck Therapeutic Peptide Product Offered
12.5.3 Merck Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Merck Main Business Overview
12.5.5 Merck Latest Developments
12.6 Novo Nordisk
12.6.1 Novo Nordisk Company Information
12.6.2 Novo Nordisk Therapeutic Peptide Product Offered
12.6.3 Novo Nordisk Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Novo Nordisk Main Business Overview
12.6.5 Novo Nordisk Latest Developments
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Therapeutic Peptide Product Offered
12.7.3 Novartis Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novartis Main Business Overview
12.7.5 Novartis Latest Developments
12.8 Johnson and Johnson
12.8.1 Johnson and Johnson Company Information
12.8.2 Johnson and Johnson Therapeutic Peptide Product Offered
12.8.3 Johnson and Johnson Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Johnson and Johnson Main Business Overview
12.8.5 Johnson and Johnson Latest Developments
12.9 Sanofi
12.9.1 Sanofi Company Information
12.9.2 Sanofi Therapeutic Peptide Product Offered
12.9.3 Sanofi Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Sanofi Main Business Overview
12.9.5 Sanofi Latest Developments
12.10 Teva
12.10.1 Teva Company Information
12.10.2 Teva Therapeutic Peptide Product Offered
12.10.3 Teva Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Teva Main Business Overview
12.10.5 Teva Latest Developments
12.11 Takeda
12.11.1 Takeda Company Information
12.11.2 Takeda Therapeutic Peptide Product Offered
12.11.3 Takeda Therapeutic Peptide Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Takeda Main Business Overview
12.11.5 Takeda Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Therapeutic Peptide Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of Other
Table 5. Global Therapeutic Peptide Sales by Type (2016-2021) & (K Units)
Table 6. Global Therapeutic Peptide Sales Market Share by Type (2016-2021)
Table 7. Global Therapeutic Peptide Revenue by Type (2016-2021) & ($ million)
Table 8. Global Therapeutic Peptide Revenue Market Share by Type (2016-2021)
Table 9. Global Therapeutic Peptide Sale Price by Type (2016-2021)
Table 10. Global Therapeutic Peptide Sales by Application (2016-2021) & (K Units)
Table 11. Global Therapeutic Peptide Sales Market Share by Application (2016-2021)
Table 12. Global Therapeutic Peptide Value by Application (2016-2021)
Table 13. Global Therapeutic Peptide Revenue Market Share by Application (2016-2021)
Table 14. Global Therapeutic Peptide Sale Price by Application (2016-2021)
Table 15. Global Therapeutic Peptide Sales by Company (2019-2021) & (K Units)
Table 16. Global Therapeutic Peptide Sales Market Share by Company (2019-2021)
Table 17. Global Therapeutic Peptide Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Therapeutic Peptide Revenue Market Share by Company (2019-2021)
Table 19. Global Therapeutic Peptide Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Therapeutic Peptide Producing Area Distribution and Sales Area
Table 21. Players Therapeutic Peptide Products Offered
Table 22. Therapeutic Peptide Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Therapeutic Peptide Sales by Region (2016-2021) (K Units)
Table 26. Global Therapeutic Peptide Sales Market Share by Region (2016-2021)
Table 27. Global Therapeutic Peptide Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Therapeutic Peptide Revenue Market Share by Region (2016-2021)
Table 29. Americas Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
Table 30. Americas Therapeutic Peptide Sales Market Share by Country (2016-2021)
Table 31. Americas Therapeutic Peptide Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Therapeutic Peptide Revenue Market Share by Country (2016-2021)
Table 33. Americas Therapeutic Peptide Sales by Type (2016-2021) & (K Units)
Table 34. Americas Therapeutic Peptide Sales Market Share by Type (2016-2021)
Table 35. Americas Therapeutic Peptide Sales by Application (2016-2021) & (K Units)
Table 36. Americas Therapeutic Peptide Sales Market Share by Application (2016-2021)
Table 37. APAC Therapeutic Peptide Sales by Region (2016-2021) & (K Units)
Table 38. APAC Therapeutic Peptide Sales Market Share by Region (2016-2021)
Table 39. APAC Therapeutic Peptide Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Therapeutic Peptide Revenue Market Share by Region (2016-2021)
Table 41. APAC Therapeutic Peptide Sales by Type (2016-2021) & (K Units)
Table 42. APAC Therapeutic Peptide Sales Market Share by Type (2016-2021)
Table 43. APAC Therapeutic Peptide Sales by Application (2016-2021) & (K Units)
Table 44. APAC Therapeutic Peptide Sales Market Share by Application (2016-2021)
Table 45. Europe Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
Table 46. Europe Therapeutic Peptide Sales Market Share by Country (2016-2021)
Table 47. Europe Therapeutic Peptide Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Therapeutic Peptide Revenue Market Share by Country (2016-2021)
Table 49. Europe Therapeutic Peptide Sales by Type (2016-2021) & (K Units)
Table 50. Europe Therapeutic Peptide Sales Market Share by Type (2016-2021)
Table 51. Europe Therapeutic Peptide Sales by Application (2016-2021) & (K Units)
Table 52. Europe Therapeutic Peptide Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Therapeutic Peptide Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Therapeutic Peptide Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Therapeutic Peptide Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Therapeutic Peptide Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Therapeutic Peptide Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Therapeutic Peptide Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Therapeutic Peptide Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Therapeutic Peptide
Table 62. Key Application and Potential Industries of Therapeutic Peptide
Table 63. Key Challenges of Therapeutic Peptide
Table 64. Key Trends of Therapeutic Peptide
Table 65. Therapeutic Peptide Distributors List
Table 66. Therapeutic Peptide Customer List
Table 67. Global Therapeutic Peptide Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Therapeutic Peptide Consumption Market Forecast by Region
Table 69. Global Therapeutic Peptide Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Therapeutic Peptide Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Therapeutic Peptide Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Therapeutic Peptide Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Therapeutic Peptide Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Therapeutic Peptide Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Therapeutic Peptide Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Therapeutic Peptide Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Therapeutic Peptide Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Therapeutic Peptide Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Therapeutic Peptide Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Therapeutic Peptide Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Therapeutic Peptide Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Therapeutic Peptide Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Therapeutic Peptide Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Therapeutic Peptide Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Therapeutic Peptide Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Therapeutic Peptide Revenue Market Share Forecast by Application (2021-2026)
Table 87. AbbVie Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Therapeutic Peptide Product Offered
Table 89. AbbVie Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. AstraZeneca Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Therapeutic Peptide Product Offered
Table 94. AstraZeneca Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Ipsen Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 98. Ipsen Therapeutic Peptide Product Offered
Table 99. Ipsen Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. Ipsen Main Business
Table 101. Ipsen Latest Developments
Table 102. Eli Lilly Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 103. Eli Lilly Therapeutic Peptide Product Offered
Table 104. Eli Lilly Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Eli Lilly Main Business
Table 106. Eli Lilly Latest Developments
Table 107. Merck Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Therapeutic Peptide Product Offered
Table 109. Merck Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Merck Main Business
Table 111. Merck Latest Developments
Table 112. Novo Nordisk Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 113. Novo Nordisk Therapeutic Peptide Product Offered
Table 114. Novo Nordisk Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Novo Nordisk Main Business
Table 116. Novo Nordisk Latest Developments
Table 117. Novartis Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Therapeutic Peptide Product Offered
Table 119. Novartis Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Johnson and Johnson Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 123. Johnson and Johnson Therapeutic Peptide Product Offered
Table 124. Johnson and Johnson Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Johnson and Johnson Main Business
Table 126. Johnson and Johnson Latest Developments
Table 127. Sanofi Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 128. Sanofi Therapeutic Peptide Product Offered
Table 129. Sanofi Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Sanofi Main Business
Table 131. Sanofi Latest Developments
Table 132. Teva Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 133. Teva Therapeutic Peptide Product Offered
Table 134. Teva Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. Teva Main Business
Table 136. Teva Latest Developments
Table 137. Takeda Basic Information, Therapeutic Peptide Manufacturing Base, Sales Area and Its Competitors
Table 138. Takeda Therapeutic Peptide Product Offered
Table 139. Takeda Therapeutic Peptide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Takeda Main Business
Table 141. Takeda Latest Developments
List of Figures
Figure 1. Picture of Therapeutic Peptide
Figure 2. Therapeutic Peptide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Peptide Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Therapeutic Peptide Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Therapeutic Peptide Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Other
Figure 12. Global Therapeutic Peptide Sales Market Share by Type in 2020
Figure 13. Global Therapeutic Peptide Revenue Market Share by Type (2016-2021)
Figure 14. Therapeutic Peptide Consumed in Cancer
Figure 15. Global Therapeutic Peptide Market: Cancer (2016-2021) & (K Units)
Figure 16. Therapeutic Peptide Consumed in Metabolic Disorders
Figure 17. Global Therapeutic Peptide Market: Metabolic Disorders (2016-2021) & (K Units)
Figure 18. Therapeutic Peptide Consumed in Central Nervous System
Figure 19. Global Therapeutic Peptide Market: Central Nervous System (2016-2021) & (K Units)
Figure 20. Therapeutic Peptide Consumed in Other
Figure 21. Global Therapeutic Peptide Market: Other (2016-2021) & (K Units)
Figure 22. Global Therapeutic Peptide Sales Market Share by Application (2016-2021)
Figure 23. Global Therapeutic Peptide Revenue Market Share by Application in 2020
Figure 24. Therapeutic Peptide Revenue Market by Company in 2020 ($ Million)
Figure 25. Global Therapeutic Peptide Revenue Market Share by Company in 2020
Figure 26. Global Therapeutic Peptide Sales Market Share by Regions (2016-2021)
Figure 27. Global Therapeutic Peptide Revenue Market Share by Region in 2020
Figure 28. Americas Therapeutic Peptide Sales 2016-2021 (K Units)
Figure 29. Americas Therapeutic Peptide Revenue 2016-2021 ($ Millions)
Figure 30. APAC Therapeutic Peptide Sales 2016-2021 (K Units)
Figure 31. APAC Therapeutic Peptide Revenue 2016-2021 ($ Millions)
Figure 32. Europe Therapeutic Peptide Sales 2016-2021 (K Units)
Figure 33. Europe Therapeutic Peptide Revenue 2016-2021 ($ Millions)
Figure 34. Middle East & Africa Therapeutic Peptide Sales 2016-2021 (K Units)
Figure 35. Middle East & Africa Therapeutic Peptide Revenue 2016-2021 ($ Millions)
Figure 36. Americas Therapeutic Peptide Sales Market Share by Country in 2020
Figure 37. Americas Therapeutic Peptide Revenue Market Share by Country in 2020
Figure 38. Americas Therapeutic Peptide Sales Market Share by Type in 2020
Figure 39. Americas Therapeutic Peptide Sales Market Share by Application in 2020
Figure 40. United States Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 41. Canada Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 42. Mexico Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 43. Brazil Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 44. APAC Therapeutic Peptide Sales Market Share by Region in 2020
Figure 45. APAC Therapeutic Peptide Revenue Market Share by Regions in 2020
Figure 46. APAC Therapeutic Peptide Sales Market Share by Type in 2020
Figure 47. APAC Therapeutic Peptide Sales Market Share by Application in 2020
Figure 48. China Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 49. Japan Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 50. Korea Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 51. Southeast Asia Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 52. India Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 53. Australia Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 54. Europe Therapeutic Peptide Sales Market Share by Country in 2020
Figure 55. Europe Therapeutic Peptide Revenue Market Share by Country in 2020
Figure 56. Europe Therapeutic Peptide Sales Market Share by Type in 2020
Figure 57. Europe Therapeutic Peptide Sales Market Share by Application in 2020
Figure 58. Germany Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 59. France Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 60. UK Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 61. Italy Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 62. Russia Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 63. Middle East & Africa Therapeutic Peptide Sales Market Share by Country in 2020
Figure 64. Middle East & Africa Therapeutic Peptide Revenue Market Share by Country in 2020
Figure 65. Middle East & Africa Therapeutic Peptide Sales Market Share by Type in 2020
Figure 66. Middle East & Africa Therapeutic Peptide Sales Market Share by Application in 2020
Figure 67. Egypt Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 68. South Africa Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 69. Israel Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 70. Turkey Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 71. GCC Country Therapeutic Peptide Revenue Growth 2016-2021 ($ Millions)
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の治療用ペプチド市場2021-2026:経口、注射、その他(Global Therapeutic Peptide Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。